CORTEX PHARMACEUTICALS INC/DE/
10QSB, EX-27, 2000-11-14
PHARMACEUTICAL PREPARATIONS
Previous: CORTEX PHARMACEUTICALS INC/DE/, 10QSB, EX-10.67, 2000-11-14
Next: CORTEX PHARMACEUTICALS INC/DE/, 424B3, 2000-11-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE BALANCE
SHEET AS OF SEPTEMBER 30, 2000, AND THE RELATED STATEMENTS OF OPERATIONS AND
CASH FLOWS FOR THE THREE-MONTHS THEN ENDED AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JUN-30-2001
<PERIOD-START>                             JUL-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                       2,939,983<F1>
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             3,032,938
<PP&E>                                       2,268,296
<DEPRECIATION>                             (1,889,253)
<TOTAL-ASSETS>                               3,445,388
<CURRENT-LIABILITIES>                        1,815,765
<BONDS>                                              0
                                0
                                     49,203
<COMMON>                                        16,582
<OTHER-SE>                                   1,563,838
<TOTAL-LIABILITY-AND-EQUITY>                 3,445,388
<SALES>                                              0
<TOTAL-REVENUES>                               716,574
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                             2,074,338
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               2,937
<INCOME-PRETAX>                              1,311,497
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          1,311,497
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 1,311,497
<EPS-BASIC>                                     (0.08)
<EPS-DILUTED>                                   (0.08)
<FN>
<F1> Includes restricted cash of $247,300.
</FN>


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission